Mark C Blaser Selected Research

Mark C Blaser Research Topics

6	Aortic Valve Disease 12/2022 - 08/2011
5	Calcinosis 01/2021 - 05/2018
4	Atherosclerosis 01/2021 - 01/2019
2	Inflammation (Inflammations) 01/2021 - 01/2020
2	Left Ventricular Dysfunction 01/2021 - 01/2018
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2021 - 01/2021
1	Left Ventricular Outflow Obstruction 12/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2022
1	Heart Valve Diseases (Valvular Heart Disease) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Obesity 01/2021
1	Hyperglycemia 01/2020
1	Atherosclerotic Plaque (Atheroma) 01/2020
1	Disease Progression 01/2018
1	Bicuspid Aortic Valve Disease 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Hypertension (High Blood Pressure) 04/2011

3	HydrogelsIBA 01/2020 - 05/2018
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
2	CollagenIBA 01/2020 - 01/2019
1	LipidsIBA 12/2022
1	LDL CholesterolIBA 12/2022
1	CalciumIBA 12/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2022
1	N 30IBA 01/2022
1	Collagen Type I (Type I Collagen)IBA 01/2022
1	prothymosin alphaIBA 01/2022
1	Estrogen Receptor alphaIBA 01/2022
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021
1	Apolipoprotein C-IIIIBA 01/2021
1	ApolipoproteinsIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Lipoprotein(a)IBA 01/2021
1	Lipid NanoparticlesIBA 01/2020
1	Apolipoproteins E (ApoE)IBA 01/2020
1	Streptozocin (Streptozotocin)FDA Link 01/2020
1	Annexin A1IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2019
1	LigandsIBA 01/2019
1	Glial Fibrillary Acidic ProteinIBA 01/2018
1	ProteomeIBA 01/2018
1	Natriuretic PeptidesIBA 01/2018
1	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 08/2011
1	Antihypertensive Agents (Antihypertensives)IBA 04/2011